SAB doses first patient with COVID-19 therapeutic
Sioux Falls-based SAB Biotherapeutics has started testing in a human patient for its therapeutic specifically developed for the virus that causes COVID-19.
Sioux Falls-based SAB Biotherapeutics has started testing in a human patient for its therapeutic specifically developed for the virus that causes COVID-19.
“I thought, ‘That is exactly what I’ve wanted from the start. This is what I need.’ ” When history, biology and religion came together at Augustana, a new minor that couldn’t be more timely was born.
Sanford’s World Clinic partnership in Costa Rica is helping bring the country best practices in fighting COVID-19.
Sioux Falls-based SAB Biotherapeutics has received an additional $35.6 million in government funding, plus $14 million in series B funding that includes a new investor – global health care leader Merck.
Meteorologist Phil Schreck has a message for other men: Try to avoid being shy about your health – it could save your life.
Wearing glasses while caring for critical COVID patients wouldn’t work for this pulmonologist. This cutting-edge vision correction approach did.
Sanford Health has started offering antibody tests for COVID-19 at nearly 50 locations.
“It’s been an incredible transformation.” In less than five years, Avera Orthopedics has grown fast — and is far from done.
A new study from Sanford Research will try to determine the prevalence of COVID-19 and learn more about its antibodies.
When the pandemic hit, this psychology practice shifted its approach fast — to serve the growing need for mental health care in Sioux Falls and beyond.